Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

Robert H. Collins, Ofer Shpilberg, William R. Drobyski, +12

Journal of Clinical Oncology

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

Craig R. Nichols, Guido Tricot, Stephen D. Williams, +7

Journal of Clinical Oncology

Cell TherapySurgical OncologyPathologyCisplatin-refractory DiseaseMetronomic Chemotherapy +17

Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma.

J P Greer, Marsha C. Kinney, Robert D. Collins, +5

Journal of Clinical Oncology

Ki-1 AlclImmunologyPathologyClinical FeaturesDermatology +16

Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.

Kenneth R. Hande, P J Wedlund, Richard M. Noone, +3

PubMed

Therapeutic Drug MonitoringUrologyMedicineChronic Kidney DiseasePharmacology +10

High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.

S N Wolff, Mehmet F. Fer, Catharine McKay, +3

Journal of Clinical Oncology

ImmunologyTransplantation MedicinePharmacotherapyMetronomic ChemotherapyRefractory Malignancies +15

Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.

G. L. Phillips, S N Wolff, JW Fay, +4

Journal of Clinical Oncology

Cell TherapyImmunologyHigh-grade GliomasMetronomic ChemotherapyImmunotherapy +15

Etoposide kinetics in patients with obstructive jaundice.

Kenneth R. Hande, S N Wolff, F. Anthony Greco, +3

Journal of Clinical Oncology

Gastrointestinal PharmacologyGastroenterologyPharmacotherapyRenal FunctionHematology +15

High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.

S N Wolff, Douglas H. Johnson, John D. Hainsworth, +1

Journal of Clinical Oncology

Cell TherapySurgical OncologyImmunologyPathologyPhase Ii Study +16

T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.

John P. Greer, William R. Macon, Robyn Lamar, +5

Journal of Clinical Oncology

In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy

S N Wolff, William W. Grosh, K. Prater, +1

Cancer Chemotherapy and Pharmacology

Pharmaceutical ScienceVitro Pharmacodynamic EvaluationMedicineClinical PharmacologyPharmacotherapy +5